Keros Therapeutics, Inc. (KROS)
10.75
-1.24
(-10.34%)
USD |
NASDAQ |
May 14, 15:28
Keros Therapeutics Price : 10.75 for May 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Sarepta Therapeutics, Inc. | 18.78 |
| PTC Therapeutics, Inc. | 73.68 |
| Insmed, Inc. | 116.59 |
| United Therapeutics Corp. | 575.92 |
| Opus Genetics, Inc. | 4.99 |
Price Related Metrics
| PE Ratio | 5.902 |
| PS Ratio | 1.646 |
| Price to Book Value | 0.6992 |
| Price to Free Cash Flow | 3.791 |
| Earnings Yield | 16.94% |
| Market Cap | 211.96M |
| Operating PE Ratio | 5.937 |
| Normalized PE Ratio | 5.896 |